Clinical Trial Update: Diet, Exercise and/or Rosiglitazone for HIV-Associated Insulin Resistance [NA]

View source ↗

Summary

A completed clinical trial evaluating diet, exercise and rosiglitazone for HIV-associated insulin resistance (with related obesity).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Insulin Resistance
• Obesity

Drugs mentioned

• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: St. Luke's-Roosevelt Hospital Center | Conditions: HIV Infections, Insulin Resistance | NA | Status: COMPLETED